These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34470689)

  • 1. Infantile recurrent respiratory papillomatosis: review of adjuvant therapies.
    Patel A; Orban N
    J Laryngol Otol; 2021 Nov; 135(11):958-963. PubMed ID: 34470689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment With Quadrivalent Human Papillomavirus Vaccine for Juvenile-Onset Recurrent Respiratory Papillomatosis: Case Report and Review of the Literature.
    Katsuta T; Miyaji Y; Offit PA; Feemster KA
    J Pediatric Infect Dis Soc; 2017 Nov; 6(4):380-385. PubMed ID: 28992265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Activity of Nivolumab for Human Papilloma Virus-Related Juvenile-Onset Recurrent Respiratory Papillomatosis.
    Creelan BC; Ahmad MU; Kaszuba FJ; Khalil FK; Welsh AW; Ozdemirli M; Grant NN; Subramaniam DS
    Oncologist; 2019 Jun; 24(6):829-835. PubMed ID: 30842242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
    Chadha NK; James A
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD005053. PubMed ID: 23235619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of paediatric laryngeal papillomas: web survey of British Association of Paediatric Otolaryngologists.
    Manickavasagam J; Wu K; Bateman ND
    J Laryngol Otol; 2013 Sep; 127(9):917-21. PubMed ID: 23927772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant antiviral therapy for recurrent respiratory papillomatosis.
    Chadha NK; James A
    Cochrane Database Syst Rev; 2010 Jan; (1):CD005053. PubMed ID: 20091568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
    Jackowska J; Piersiala K; Klimza H; Wierzbicka M
    Otolaryngol Pol; 2018 Jun; 72(4):1-8. PubMed ID: 30190442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Safety of Intralesional Cidofovir for Adjuvant Treatment of Recurrent Respiratory Papillomatosis.
    Hoesli RC; Thatcher AL; Hogikyan ND; Kupfer RA
    JAMA Otolaryngol Head Neck Surg; 2020 Mar; 146(3):231-236. PubMed ID: 31895450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment and adjuvant therapies of recurrent respiratory papillomatosis.
    Avelino MA; Zaiden TC; Gomes RO
    Braz J Otorhinolaryngol; 2013; 79(5):636-42. PubMed ID: 24141682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is recurrent respiratory papillomatosis a manageable or curable disease?
    Kim HT; Baizhumanova AS
    Laryngoscope; 2016 Jun; 126(6):1359-64. PubMed ID: 26608928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of intralesional cidofovir in the recurrent respiratory papillomatosis: a review of the literature.
    Gazia F; Galletti B; Freni F; Bruno R; Sireci F; Galletti C; Meduri A; Galletti F
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):956-962. PubMed ID: 32017003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intralesional cidofovir injections for recurrent laryngeal papillomatosis: first results].
    Neumann K; Pudszuhn A; Welzel C; Bartel-Friedrich S; Passmann M
    Laryngorhinootologie; 2003 Oct; 82(10):700-6. PubMed ID: 14593568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent respiratory papillomatosis by HPV: review of the literature and update on the use of cidofovir.
    Fusconi M; Grasso M; Greco A; Gallo A; Campo F; Remacle M; Turchetta R; Pagliuca G; DE Vincentiis M
    Acta Otorhinolaryngol Ital; 2014 Dec; 34(6):375-81. PubMed ID: 25762828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis.
    Allen CT; Lee S; Norberg SM; Kovalovsky D; Ye H; Clavijo PE; Hu-Lieskovan S; Schlegel R; Schlom J; Strauss J; Gulley JL; Trepel J; Hinrichs CS
    J Immunother Cancer; 2019 May; 7(1):119. PubMed ID: 31053174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cidofovir and the measles, mumps, and rubella vaccine in the treatment of recurrent respiratory papillomatosis.
    Meacham RK; Thompson JW
    Ear Nose Throat J; 2017 Feb; 96(2):69-74. PubMed ID: 28231366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional Cidofovir application in recurrent laryngeal papillomatosis.
    Pudszuhn A; Welzel C; Bloching M; Neumann K
    Eur Arch Otorhinolaryngol; 2007 Jan; 264(1):63-70. PubMed ID: 17058091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pegylated interferon for treating severe recurrent respiratory papillomatosis in a child: case report.
    Maunsell R; Bellomo-Brandão MA
    Sao Paulo Med J; 2018; 136(4):376-381. PubMed ID: 28977096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis.
    Wierzbicka M; Jackowska J; Bartochowska A; Józefiak A; Szyfter W; Kędzia W
    Eur Arch Otorhinolaryngol; 2011 Sep; 268(9):1305-11. PubMed ID: 21519834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan.
    Murono S; Nakanishi Y; Tsuji A; Endo K; Kondo S; Wakisaka N; Yoshizaki T
    Auris Nasus Larynx; 2016 Oct; 43(5):541-5. PubMed ID: 26860235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voice improvement in patients with recurrent respiratory papillomatosis after combined treatment with cidofovir and CO
    Jackowska J; Wojnowski W; Hashimoto A; Małaczyńska B; Piersiala K; Świdziński P; Wiskirska-Woźnica B; Wierzbicka M
    Lasers Med Sci; 2019 Sep; 34(7):1433-1440. PubMed ID: 30762194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.